Introduction

GLIEMPAFLOZIN MET ER is an extended-release medication designed to provide effective management of type 2 diabetes. It combines Empagliflozin (25mg) and Metformin Hydrochloride (1000mg, Extended Release) in one tablet, delivering long-lasting effects for better blood sugar control. This combination of medications helps patients manage their condition by targeting different aspects of glucose regulation, offering both immediate and prolonged benefits.

Composition of GLIEMPAFLOZIN MET ER

Each tablet of GLIEMPAFLOZIN MET ER contains:

• Empagliflozin (25mg): An SGLT-2 inhibitor that reduces glucose reabsorption in the kidneys, promoting the excretion of excess glucose in the urine.
• Metformin Hydrochloride (1000mg, Extended Release): A biguanide that decreases glucose production in the liver and enhances insulin sensitivity, making the body more efficient in using glucose.

The extended-release (ER) formulation of Metformin allows for gradual release of the medication throughout the day, reducing the risk of gastrointestinal side effects and offering smoother blood sugar control.

Key Features and Ingredients

1. Empagliflozin (25mg):

   • Mechanism of Action: Inhibits the SGLT-2 transporter in the kidneys, leading to increased glucose excretion through urine, helping lower blood sugar levels.
   • Primary Benefit: Helps control blood glucose by reducing glucose levels in the blood and promoting the elimination of excess glucose from the body.

2. Metformin Hydrochloride (1000mg, Extended Release):

   • Mechanism of Action: Reduces hepatic glucose production (glucose output by the liver) and improves the body’s sensitivity to insulin, allowing for better glucose uptake by cells.
   • Primary Benefit: Helps the body use insulin more effectively and controls blood sugar levels while minimizing glucose production in the liver.

Usage

GLIEMPAFLOZIN MET ER is typically prescribed to adults with type 2 diabetes to help manage blood sugar levels in conjunction with a proper diet and exercise regimen. The extended-release formulation is taken once daily, usually with food, to improve tolerance and reduce gastrointestinal discomfort. The dosage and frequency may vary based on individual needs, so it's important to follow the specific instructions from a healthcare provider.

Benefits of GLIEMPAFLOZIN MET ER

1. Extended-Release Action for Smoother Blood Sugar Control: The extended-release formulation of Metformin helps provide sustained blood glucose control throughout the day, reducing peaks and troughs in blood sugar levels. This makes it a great option for patients who need consistent glucose management.

2. Dual Action on Blood Sugar: The combination of Empagliflozin and Metformin works synergistically to control blood sugar in multiple ways:

   • Empagliflozin helps to remove excess glucose through the kidneys.
   • Metformin reduces glucose production and improves insulin sensitivity.

   Together, they offer comprehensive control over blood sugar, reducing the risk of hyperglycemia (high blood sugar).

3. Weight Management: Empagliflozin has been shown to promote modest weight loss, which is beneficial for individuals with type 2 diabetes who are overweight or obese. This can further enhance overall health and improve insulin resistance.

4. Cardiovascular Protection: Empagliflozin has also been linked to cardiovascular benefits, including reducing the risk of heart failure and improving heart function, which is especially important for those with diabetes who are at higher risk of cardiovascular diseases.

5. Reduced Gastrointestinal Side Effects: The extended-release nature of Metformin reduces the likelihood of common gastrointestinal side effects like nausea and diarrhea, which are often associated with standard Metformin formulations.

FAQ Section

1. What is GLIEMPAFLOZIN MET ER used for?

GLIEMPAFLOZIN MET ER is used for the management of type 2 diabetes in adults. It helps control blood sugar levels through the combined actions of Empagliflozin and Metformin Hydrochloride.

2. How does GLIEMPAFLOZIN MET ER work?

Empagliflozin (25mg) works by inhibiting the SGLT-2 transporter in the kidneys, promoting glucose excretion in urine. Metformin Hydrochloride (1000mg, ER) works by reducing glucose production in the liver and improving insulin sensitivity.

3. What are the advantages of the extended-release (ER) form of Metformin?

The extended-release (ER) form of Metformin allows for gradual release of the medication, providing smoother control of blood sugar levels and reducing gastrointestinal side effects like nausea and diarrhea, which are common with immediate-release forms.

4. What are the potential side effects of GLIEMPAFLOZIN MET ER?

Possible side effects may include low blood sugar (hypoglycemia), urinary tract infections, nausea, and diarrhea. The extended-release form of Metformin generally reduces the risk of gastrointestinal side effects compared to the regular form.

5. Can GLIEMPAFLOZIN MET ER be taken with other diabetes medications?

In some cases, GLIEMPAFLOZIN MET ER can be used with other diabetes medications, such as insulin or sulfonylureas. However, it's important to consult your healthcare provider to avoid the risk of hypoglycemia or other drug interactions.

6. Can GLIEMPAFLOZIN MET ER cause weight loss?

Yes, Empagliflozin has been associated with modest weight loss in some individuals, which can be beneficial for those with type 2 diabetes who need to manage their weight.

7. Can I take GLIEMPAFLOZIN MET ER during pregnancy or breastfeeding?

GLIEMPAFLOZIN MET ER is not recommended for use during pregnancy. If you are pregnant or planning to become pregnant, consult your doctor. Additionally, if you are breastfeeding, it's important to talk to your healthcare provider before taking this medication.

Conclusion

GLIEMPAFLOZIN MET ER (25mg/1000mg) is a highly effective combination medication for managing type 2 diabetes, offering dual-action blood sugar control through the synergistic effects of Empagliflozin and Metformin Hydrochloride (extended release). This medication not only helps lower blood sugar but also supports weight management, improves insulin sensitivity, and may offer cardiovascular benefits. If you are struggling with blood sugar management, talk to your healthcare provider about whether GLIEMPAFLOZIN MET ER is the right choice for your treatment plan.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW